Having trouble viewing this email? View it in your browser.
Musella Foundation Logo and Name of Email Blast
Monday, August 26, 2024
Issue 5986
Donations

Advocacy
Alert

The time has come to rally for the Promising Pathway Act!

Click for details and to easily send letters.

Latest News

  • 2025 College Scholarship $ is Available!        

    From our friends at the George Bartol Memorial Scholarship Fund:

    Hello everyone! We are excited to honor our father for the 20th year in granting scholarships! Applications for the George Bartol Memorial Scholarship Fund are due by October 1, 2024. Winners will each receive $3k towards their educational expenses in 2025. Please reach out for an application if you meet the criteria below!

    Criteria to apply:
    1. Lost a parent or have a parent battling brain cancer. (Primary in origin, not metastatic.)
    2. Degree seeking student at any US college or university.
    3. 2.5 GPA or better
    4. 23 years of age or less

    *** Applications are due no later than October 1, 2024. Please send a message to the George Bartol Memorial Scholarship Fund on Facebook to request an application. 


  • Metabolic signatures derived from whole-brain MR-spectroscopy identify early tumor progression in high-grade gliomas using machine learning        

    Researchers at the University of Miami are using whole-brain MR-spectroscopy (WB-MRS) and a new machine learning technique to predict brain tumor recurrence much sooner than detection on traditional MRI scans. WB-MRS provides detailed metabolic information across the entire brain, allowing for a more comprehensive view of tumor activity. While this was only a small pilot study, we hope to see broader application and validation of WB-MRS predictive models going forward. 


  • Boy, 11, denied life-extending drug as his incurable 'octopus tumour' is 1 millimetre too small        

    This is a UK story, but we see this happen to patients every day in the US. Clinical trial inclusion/exclusion criteria are extremely rigid, and only a small percentage of brain tumor patients are able to qualify for the most promising trials. It's heartbreaking, and it's exactly why we need everyone's support for the Promising Pathway Act. 



Sponsored By
Cleveland Clinic Brain Tumor and Neuro-Oncology Center
Please Click On The Above Banner For More Details

To view past stories go to : https://virtualtrials.org/newsblast.cfm
To submit a story/press release go to: click here To unsubscribe, click here.
The article commentaries are the opinions of Al Musella, DPM and do not represent the official position of the Musella Foundation. Copyright 1992-2024 Musella Foundation - All rights reserved. No part of the Brain Tumor News Blast can be reproduced without the express written permission of the Musella Foundation.